The European Commission’s EU State aid investigations into the tax ruling practices of EU countries […]
Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, […]
Battles in the pharmaceutical antitrust world have been increasingly heated, and to a great extent […]
#74 Will the Past Repeat Itself? Understanding the Implications of the Government’s Case Against IBM
U.S. antitrust dealing with tech ranges from early government cases involving punch cards to the […]
Digital platforms host more and more of our daily activities. Many are free and seem […]
This special episode is the audio of a program that ran during the ABA Antitrust […]
This special episode is the audio of a program that ran during the ABA Antitrust […]
Companies are increasingly relying on artificial intelligence technologies to guide product pricing, output and innovation […]
Recent economic research has examined potential killer acquisitions in the U.S., and regulators here and […]
This past year saw an increasing number of jurisdictions around the world opening investigations or […]